Vitai Robotics

Established in 2024 and based in Shanghai, China, Vitai Robotics operates as a robotic system developer that focuses on the research, development, and manufacturing of robot bionic perception systems. Its core team comes from the Computer Science and Artificial Intelligence Laboratory (CSAIL) of the Massachusetts Institute of Technology. In April 2025, the company closed angel+ funding from new investor Vertex Ventures China and returning investors Y&R Capital, iCANX Fund, Plum Ventures, and Welight Capital. The company focuses on the research and development of robot bionic perception systems.

Its main product is the GelFinger, a gripper with tactile sense based on the visual GelSight sensor technology. It is a robot bionic fingertip and tactile end effector product with high-resolution tactile perception, multi-dimensional force detection, and flexible object manipulation capabilities. The company generates revenue by providing robot bionic perception systems and robot bionic fingertip and tactile end effector product. The company plans to establish cooperation with scientific research institutions and OEMs in early 2025 to achieve the initial implementation of GelFinger business and ship nearly 100 sets.

From 2026 to 2027, it will solve the problems in the field of complex C-end commercial scenarios, start the layout of 2B2C end collaborative whole machine products, and lay out the next generation of general robots.